The content on this site is intended for healthcare professionals only
Prof Hubert Serve talks to ecancer about the German Consortium for Translational Cancer Research at the European Forum on Oncology in Berlin, May 2012.
The German Federal government funds the consortium, which promotes research through improving clinical communication platforms. These platforms bring results from the lab to the clinic, and make data available to other institutes. The consortium also aims to prioritise and monitor clinical trial activity within its institutes and provide an improved patient based workflow.
Addressing the rise of multiple myeloma in Rwanda
Research highlights in gastrointestinal tumours
GIST tumours and soft tissue sarcomas
Adagrasib shows durable clinical benefit in advanced KRAS-mutant NSCLC
TARGeted IORT INTRABEAM is a useful treatment option for early stage breast cancer
Tusamitamab ravtansine combined with SoC shows encouraging anti-tumour activity for patients with nonsquamous NSCLC
Initial results from a phase 1 dose escalation trial of E-602 shows efficacy in solid tumours
Combination of camonsertib plus PARPi shows clinical activity in DDR-aberrant tumours
African oncologists interaction with pharmaceutical industry
